TOKYO--(BUSINESS WIRE)--In Tokyo, from May 8th to 10th, Asia's largest bio event "BIOtech 2013 in Japan" took place showing a significant growth both in the scale and the quality. Check the key figures below to see how successful the show was.
・603 exhibitors from 25 countries (UP from 490 exhibitors
from 15 countries in 2012)
・10,362 visitors from around the
world
・237 presentations
・4,845 attendees to the
Keynote & Special Sessions
The Japanese bio industry gaining huge attention: Increased attendance from overseas
One of the many factors which lead BIOtech 2013 Japan to the huge
success was that the Japanese bio industry is showing signs of recovery
and further growth. Dr. Yamanaka's creation of iPS cells not only
generated the new market for iPS cell research and regenerative
medicine, also became a cause for the government to enhance its support
toward the bio/pharma-related research. Also fueled by newcomers from
other industries, business and innovation in the Japanese bio industry
is rejuvenated.
Growing interests toward the Japanese market also
resulted in an increased number of attendees from overseas. Due to the
economic stagnation in Europe, more overseas biotech companies have
chosen to exhibit at the show, setting their target to Japan. Partly
because of that, the number of overseas exhibitors almost doubled from
the previous show. Also, increased numbers of overseas visitors were
seen having active business talks, attracted by the latest research
achievements/products presented at the show.
This year, BIOtech
Japan has further established its position as an international event
where the Japanese/Asian bio industry and those who are targeting it all
get together, as THE STATE OF ILLINOIS (exhibitor) said: "This is THE
must-attend event for those targeting the Japanese market."
Highlights of BIOtech 2013 Japan (Consists of "Partnering", "Exhibition" and "Conference")
・Partnering
The number of appointments set through "Bio
Partnering System" has almost doubled this year, especially between
academics and the industry sector. As many as 176 academic presenters
participated in Bio Partnering System and presented their latest
research achievements at Academic Forum on-site. Many pharmaceutical
companies (including the world's leading companies represented as Sponsors)
actively participated in partnering, choosing BIOtech Japan as the best
way to find prominent platform technologies/seeds.
・Exhibition
Not only the number of exhibitors increased
significantly from the previous years, there were some substantial
changes also in the lineup of exhibitors.
Firstly, almost all the
global leaders exhibited here, some of them coming back after a few
years of break.
Secondly, there was increased number of overseas
exhibitors, especially from Europe. There were many positive feedbacks
also from first-time exhibitors, saying they could get a foothold in the
Japanese market, finding agents and powerful users.
Thirdly, the
show was joined by many newcomers from other industries and
venture/start-up companies, especially at the NEW "Table-top exhibiting
area".
Collecting a variety of exhibitors, the show further
established its position as the hub of the Asian bio industry. >>Exhibitors
List 2013
・Conference
Keynote Session and 10 lines of Special Sessions
attracted 4,845 attendees in total, covering the hot topics such as stem
cells, regenerative medicine, orphan drug, antibody drug, personalized
medicine, and so on. >>Full
Program
Next show in May 2014
BIOtech 2014 Japan will take place from May 14 to 16, 2014 at Tokyo Big
Sight, becoming larger and more international.
More information: www.bio-t.jp/en/
